Skip to main content
. 2022 Nov 10;12:19164. doi: 10.1038/s41598-022-23281-y

Table 1.

Minimal inhibitory concentration and minimal bactericidal concentrations (MIC/MBC; µg/mL) of CSA-13, CSA-44 and CSA-131 against Escherichia coli Xen14 and two clinical strains of uropathogenic E. coli (S1 and S2) isolated from patients with urinary tract infections.

CSA-13 CSA-44 CSA-131
E. coli Xen14 2/2 4/8 1/2
E. coli S1* 1/2 2/4 1/2
E. coli S2* 2/4 2/4 2/4

*Clinical strain.